Livzon Pharmaceutical Group Inc. (1513.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.88B |
| Enterprise Value | 17.42B |
| P/E Ratio | 18.02 |
| PEG Ratio | -0.67 |
| Price/Sales Ratio | 2.44 |
| Price/Book Ratio | 2.15 |
| Enterprise/Revenue | 2.14 |
| Enterprise/EBITDA | 9.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 12.02B |
| Revenue/Share | 11.51 |
| Gross Profit | 7.92B |
| EBITDA | 3.1B |
| Net Income | 2.02B |
| Diluted EPS | 2.27 |
Balance Sheet
| Total Cash | 7.31B |
| Total Cash/Share | 8.24 |
| Total Debt | 4.2B |
| Total Debt/Equity | 0.32 |
| Current Ratio | 1.48 |
| Book Value Per Share | 15.92 |
Price History
| 52-Week Change | -23.32 |
| 52-Week High | 33.18 |
| 52-Week Low | 19.8 |
| Moving Average 50 Days | 21.81 |
| Moving Average 200 Days | 25.69 |
Statistics
| Average Volume | 1.66M |
| Shares Outstanding | 1.09B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.45 |
| Trailing Annual Dividend Yield | 7.77 |
| Payout Ratio | 1.01 |
| Last Split Factor | 13:10 |
| Last Split Date | July 03, 2019 |
AD
